Results 241 to 250 of about 84,630 (297)

Transdiagnostic and symptom‐domain associations between mental illnesses and future self‐connectedness versus future self‐valence

open access: yesJCPP Advances, EarlyView.
Abstract Background Future time perspective dimensions have been linked to various mental illnesses. Given the tendency for mental illnesses to co‐occur, it is necessary to disentangle associations between future‐oriented constructs and shared versus symptom‐domain‐specific psychopathology.
Yi Yang   +6 more
wiley   +1 more source

Curriculum Guidelines for Social and Behavioral Sciences in Predoctoral Dental Education

open access: yesJournal of Dental Education, EarlyView.
ABSTRACT Social and behavioral sciences are an integral part of predoctoral dental education, given the important role of social and behavioral factors in oral health, dentist‐patient communication, the provision of person‐centered care, and patients’ experience of dental treatment and their treatment outcomes.
Cameron L. Randall   +10 more
wiley   +1 more source

Heated Tobacco Products: Current Evidence of Pulmonary Harm and Lung Cancer Risk. [PDF]

open access: yesCureus
Albuquerque BL   +4 more
europepmc   +1 more source

Smoking Cessation Inertia in Diabetes Care. [PDF]

open access: yesJ Diabetes
Adebisi YA, Misra A, Polosa R.
europepmc   +1 more source

Tobacco, nicotine and harm reduction

open access: yesDrug and Alcohol Review, 2011
AbstractIssues. Tobacco smoking, sustained by nicotine dependence, is a chronic relapsing disorder, which in many cases results in lifelong cigarette use and consequent death of one out of two lifelong smokers from a disease caused by their smoking. Most toxicity due to cigarette smoking is related to the burning process. Approach.
Ann Mcneill
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Harm reduction policies for tobacco users

open access: yesInternational Journal of Drug Policy, 2010
Tobacco harm reduction is a controversial policy due to the experience with filtered and 'light' cigarettes and concerns that the tobacco industry will use reduced harm products to undermine tobacco control strategies. The most promising harm reduction products are high dose pharmaceutical nicotine preparations and low nitrosamine smokeless tobacco ...
Gartner, C, Hall, W
openaire   +6 more sources

Home - About - Disclaimer - Privacy